Ask AI
ProCE Banner Activity

PURPOSE 2: Adherence to and Safety of Lenacapavir for PrEP Among People Who Use Substances

Conference Coverage
Slideset

In analysis of phase III study of cisgender men and gender-diverse people who have sex with men who self-reported substance use at baseline, high rates of adherence to SC LEN and acceptable safety profile observed.

Released: October 24, 2025

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare